The event raised more than $1.5 million, which will help support evidence-based research, pharmacy education and philanthropic initiatives to improve patient outcomes and advance population health.
Target reported Q3 GAAP earnings per share of $1.54, down 49.3% from $3.04 in 2021 and adjusted EPS of $1.54, a decrease of 49.1% compared with $3.03 in 2021.